Lilly and Novo Show How AI Is Rewiring Big Pharma
Eli Lilly and Novo Nordisk, the two companies that dominate the global market for GLP-1 weight loss and diabetes drugs, are each deploying artificial intelligence (AI) across different stages of drug ...
ECB Blockchain Report Challenges DeFi’s Decentralization Claims
Decentralized finance (DeFi) has, since its inception, sold itself on one premise: a financial system without intermediaries, governed collectively by its users through transparent, blockchain-based m...